01.12.2015
AURELIUS SE & Co. KGaA DE000A0JK2A8
DGAP-News: AURELIUS acquires Allied Healthcare from Saga plc
DGAP-News: AURELIUS SE & Co. KGaA / Key word(s): Acquisition
AURELIUS acquires Allied Healthcare from Saga plc
01.12.2015 / 13:51
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
AURELIUS acquires Allied Healthcare from Saga plc
Munich / London, 1 December 2015 - AURELIUS Group (ISIN DE000A0JK2A8)
("AURELIUS"), the pan-European, mid-market investor, today announces the
acquisition of Allied Healthcare ("the Company"), the UK's largest
domiciliary care business and a leading provider of outsourced healthcare
services to the English primary care sector, from Saga plc.
The assets of Allied Healthcare acquired by AURELIUS comprise the following
businesses:
- Visiting Care: Britain's largest provider of domiciliary care by market
share and a provider of complex care services in the home to
individuals with critical needs, commissioned by both Local Authorities
and Clinical Commissioning Groups (CCGs).
- Primecare: A provider of outsourced primary healthcare services, such
as out-of-hours GP services, walk-in centres and dental practices, on
behalf of public sector bodies in England including CCGs and National
Health Service (NHS) Trusts. Additionally, Allied Nursing provides an
agency service for temporary clinical/medical staff.
- Homecare Independent Living (HCIL): a home-based care and other housing
and support services provider in which Allied Healthcare holds a
majority interest, with operations in both Northern Ireland, where it
is the leading domiciliary care provider, and the Republic of Ireland.
Allied Healthcare is the leading domiciliary care business in the UK and
has over 12,000 employees; in 2014 the Company recorded revenues of £282m
(approx. EUR400m).
Commenting on the acquisition, Dirk Markus, Chief Executive of AURELIUS
Group, said: "As a non-core asset of Saga, Allied Healthcare is a special
situation investment that meets the AURELIUS investment criteria on many
levels. AURELIUS regards the acquisition of Allied as an opportunity to
further grow and develop the Company's market leading position in the
visiting care market - a critical service that supports the community care
sector. Allied is a mature business with strong fundamentals; it has
suffered from a number of legacy operational inefficiencies but we are
confident that these can be streamlined."
Tristan Nagler, Managing Director of AURELIUS in the UK, commented: "The
enormous pressures facing vital UK care service providers like Allied
Healthcare as a result of cuts to Local Authority funding and the impending
introduction of the National Living Wage are well known. AURELIUS'
operationally engaged approach means it is well positioned to give Allied
the actively managed operational backing required to weather these
challenges and ultimately build a strong and sustainable business in a
sector that continues to grow year on year.
"This is the second complex carve-out transaction that AURELIUS has made in
the UK in Q4 2015; the deal further evidences our relevance for major UK
corporates, such as Saga, seeking investment solutions for non-core
assets."
The acquisition of Allied Healthcare, combined with 10 other successful
investments in 2015, will take AURELIUS' annualised sales to over EUR3bn.
Last week, AURELIUS announced the approval of EUR166.3m of senior,
unsecured convertible bonds due in 2020 which will provide the Group with a
strong financial basis to support the organic and acquisitive growth of its
investment portfolio.
ABOUT AURELIUS
AURELIUS is one of the leading European investment groups. From its offices
in Munich, London, Stockholm and Madrid, AURELIUS acquires participations
with development potential. Once under the AURELIUS umbrella, the
acquisitions are given a long-term strategic orientation in order for them
to fully develop their potential.
Currently, the AURELIUS Group consists of 22 subsidiaries with locations in
Europe, Asia, and the U.S.A. These include numerous traditional consumer
brands, services businesses and a number of industrial enterprises.
Companies are acquired based on strict investment criteria without focusing
on any particular industry. Shares of AURELIUS SE & Co. KGaA are listed in
the m:access segment of the Munich Stock Exchange and are traded on all
German stock markets under ISIN DE000A0JK2A8.
To find out more, visit www.aureliusinvest.com
CONTACT
Anke Banaschewski
Investor Relations & Corporate Communications
Phone +49 (89) 544799 - 0
Fax +49 (89) 544799 - 55
[email protected]
About Allied Healthcare
Allied Healthcare is the UK's largest domiciliary care business, with more
than twice the market share of its nearest competitor, as well as a leading
provider of healthcare services to the NHS and local government and the
majority owner of a major Irish homecare provider.
The company has over 100 community based branches with around 12,000
employees. It works with 140+ Local Authorities located across England,
Scotland, and Wales, and 100+ NHS Clinical Commissioning Groups.
For more information, visit www.alliedhealthcare.com/
---------------------------------------------------------------------------
01.12.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
420061 01.12.2015
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
AURELIUS SE & Co. KGaA ISIN: DE000A0JK2A8 können Sie bei EQS abrufen
Beteiligungen , A0JK2A , AR4 , HAM:AR4